Medical devices, healthcare technology and the business of care
PMA approval · P040036

NAVISTAR THERMOCOOL DEFLECTABLE DIAGNOSTIC/ABLATION CATHETER

Biosense Webster, Inc. · Decision date Aug 11, 2006

MEDTECHLEDGER EXPLANATIONP040036

What did the FDA approve?

FDA approved the NAVISTAR THERMOCOOL deflectable diagnostic/ablation catheters, covering models N175TBH, N175TCH, N175TDH, N175TFH, N175TCBH, N175TCCH, N175TCDH, N175TCFH, and N175TCJH. The approval states that these catheters, used with the Stockert 70 RF generator, are indicated for treating recurrent drug/device refractory sustained monomorphic ventricular tachycardia due to prior myocardial infarction in adults.

The same statement reports that the catheter provides location information when used with the CARTO EP/XP navigation system and can be used for catheter-based cardiac electrophysiological mapping, including stimulation and recording. The source does not include supplement type or reason fields, so no information is available about whether this decision modified an earlier submission or represented the original approval scope.

FDA approval order statement

APPROVAL FOR THE NAVISTAR THERMOCOOL DEFLECTABLE DIAGNOSTIC/ABLATION CATHETERS WHICH INCLUDE MODELS N175TBH, N175TCH, N175TDH, N175TFH, N175TCBH, N175TCCH, N175TCDH, N175TCFH, AND N175TCJH. THE NAVISTAR THERMOCOOL DIAGNOSTIC/ABLATION DEFLECTABLE TIP CATHETER AND RELATED ACCESSORY DEVICES, WHEN USED WITH THE STOCKERT 70 RADIOFREQUENCY (RF) GENERATOR, ARE INDICATED FOR THE TREATMENT OF RECURRENT DRUG/DEVICE REFRACTORY SUSTAINED MONOMORPHIC VENTRICULAR TACHYCARDIA (VT) DUE TO PRIOR MYOCARDIAL INFARCTION (MI) IN ADULTS.THE NAVISTAR THERMOCOOL CATHETER PROVIDES LOCATION INFORMATION WHEN USED WITH THE CARTO EP / XP NAVIGATION SYSTEM, AND CAN BE USED FOR CATHETER-BASED CARDIAC ELECTROPHYSIOLOGICAL MAPPING (STIMULATION AND RECORDING).
Regulatory pathway
Original PMA
Clinical specialty
Cardiovascular
Decision date
Aug 11, 2006

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
P040036
Regulatory pathway
Premarket approval application
Product code
LPB
Decision code
APPR
Decision date
Aug 11, 2006
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Cardiac ablation percutaneous catheter.

Product code
LPB
FDA device class
3

The approval statement above describes the scope recorded for this original decision. Later supplements may change the device or its indications.

FDA decision timeline

  1. P040036 received

    Application receipt date recorded by FDA.

  2. P040036 · FDA decision

    APPR

  3. P040036/S101 · Related supplement

    THERMOCOOL SMARTTOUCH BI-DIRECTIONAL NAVIGATION CATHETER; THERMOCOOL SMARTTOUCH UNI-DIRECTIONAL NAVIGATION CATHETER

Timeline entries are records held by MedtechLedger for P040036. View FDA’s full supplement list.

Related devices and submissions

Same PMA: P040036

Product / regulatory recordCompanyPathwayDecision dateSource
Biosense Webster, Inc.PMA supplementSep 15, 2026FDA

Explore the linked device profile

Other records with product code LPB

Product / regulatory recordCompanyPathwayDecision dateSource
Irvine Biomedical, Inc.PMA supplementSep 3, 2026FDA
Irvine Biomedical, Inc.PMA approvalJan 14, 2005FDA

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

An original PMA is a premarket approval application. The recorded approval scope is described in FDA’s order and supporting documents.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Biosense Webster, Inc.

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
31 Technology Dr., Suite 200, Irvine, CA, 92618

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records